Wei Lin
Chief Tech/Sci/R&D Officer bei REVOLUTION MEDICINES, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Wei Lin is currently an Independent Director at 2seventy Bio, Inc. and the Chief Medical Officer at Revolution Medicines, Inc. Previously, he held the position of Senior Vice President-Clinical Development at Nektar Therapeutics from 2018 to 2021.
From 2006 to 2009, he served as the Site Head-Oncology Product Development at Roche (China) Co. Ltd.
Dr. Lin was also the Chief Medical Officer at Erasca, Inc. from 2021 to 2023.
Additionally, he held a position at Genentech, Inc. as the Head-Neck Cancers.
Dr. Lin completed his undergraduate studies at Haverford College and obtained his doctorate degree from Harvard Medical School in 2004.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.03.2024 | 74 400 ( 0,05% ) | 2 Mio $ | 31.03.2024 | |
2SEVENTY BIO, INC.
0,04% | 13.06.2023 | 20 800 ( 0,04% ) | 111 280 $ | 31.03.2024 |
Aktive Positionen von Wei Lin
| Unternehmen | Position | Beginn |
|---|---|---|
| 2SEVENTY BIO, INC. | Director/Board Member | 07.03.2023 |
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 01.04.2023 |
Ehemalige bekannte Positionen von Wei Lin
| Unternehmen | Position | Ende |
|---|---|---|
| ERASCA, INC. | Chief Tech/Sci/R&D Officer | 10.04.2023 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 05.01.2021 |
| Roche (China) Co. Ltd. | Corporate Officer/Principal | 01.01.2009 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Wei Lin
| Haverford College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Roche (China) Co. Ltd. |
